// App-Quantinova.ai

P935 : REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY

Researchers

Presenter

  • Hermann Einsele

Principal Investigators

  • Philippe Moreau

  • Michel Delforge

  • Niels WCJ van de Donk

  • Joris Diels

  • Vadim Strulev

  • Lixia Pei

  • Rachel Kobos

  • Jennifer Smit

  • Mary Slavcev

  • Katja Weisel

  • Maria-Victoria Mateos

Medical Centers

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Development, LLC,Spring House, PA,Vereinigte Staaten

  • Janssen-Cilag, High Wycombe,Buckinghamshire,Royaume-uni

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Janssen-Cilag SpA,Cologno Monzese,États-unis

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • Janssen Global Services,Raritan,Estados Unidos

  • Janssen Global Services,Raritan,Estados Unidos

  • University of Leuven,Leuven,Bélgica

  • Development,Raritan, NJ,Vereinigte Staaten

  • University Hospital of Salamanca, Salamanca, Spain

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Janssen-Cilag, High Wycombe,Buckinghamshire,Royaume-uni

  • University Medical Center Utrecht,

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Janssen Global Services,Raritan,Vereinigte Staaten

  • Dev

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University of Leuven, KUL, Leuven, Belgium

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Hematology Biology, University Hospital Hotel Dieu, Nantes, France

  • Janssen-Cilag SpA,Cologno Monzese,United States

  • Development,Raritan, NJ,Vereinigte Staaten

  • Development,Raritan,United States

  • Janssen-Cil

  • University Hospital of Salamanca, Salamanca, Spain

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • University Hospital of Salamanca, Salamanca, Spain

  • University of Leuven,Leuven,Bélgica

  • Janssen Research &amp

  • Development, LLC,Spring House, PA,Vereinigte Staaten

  • Development, LLC,Raritan, NJ,États-unis

  • Janssen-Cilag SpA,Cologno Monzese,United States

  • Janssen Global Services,Raritan,Estados Unidos

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Janssen Global Services, Raritan, NJ

  • University Hospital of Salamanca, Salamanca, Spain

  • Janssen-Cilag, High Wycombe,Buckinghamshire,Royaume-uni

  • Development,Raritan,Stati Uniti

  • Development,Spring House, PA,Stati Uniti

  • Universitätsklinikum Würzburg, Medizinische Klini

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Janssen-Cilag SpA,Cologno Monzese,États-unis

  • University of Leuven, KUL, Leuven, Belgium

  • Development, LLC,Spring House, PA,Estados Unidos

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Development,Raritan,Estados Unidos

  • Janssen Pharmaceutica NV, Beerse, Belgium

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University of Leuven, KUL, Leuven, Belgium

  • Development, LLC,Spring House,United States

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Janssen-Cilag, High Wycombe,Buckinghamshire,Vereinigtes Königreich

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Amsterdam University Medical Center, Vrije Unive

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Janssen Global Services, Raritan, NJ, United States

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Janssen-Cilag, High Wycombe,Buckinghamshire,Vereinigtes Königreich

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • Janssen-Cilag SpA,Cologno Monzese,United States

  • Janssen-Cilag, Buckinghamshire, United Kingdom

  • Janssen-Cilag, High Wycombe,Buckinghamshire,Royaume-uni

  • Janssen Global Services,Raritan,Vereinigte Staaten

  • University of Leuven, KUL, Leuven, Belgium

  • Janssen-Cilag SpA,Cologno Monzese,États-unis

  • University Hospital of Salamanca

  • Development,Spring House,États-unis

Locations

  • Germany

  • France

  • Belgium

  • United States

  • Italy

  • United Kingdom

  • Mexico

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • I/II

Study Id's

  • NCT04557098

  • NCT04035226

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved